
PT-141 10mg | 20-Vial Kit | Bremelanotide Kit
About this compound
PT-141 10mg | 20-Vial Kit — Bremelanotide MC3R/MC4R agonist — activates hypothalamic melanocortin receptors to drive central sexual arousal independently of vascular mechanisms; FDA-approved mechanism for HSDD research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Certificate of Analysis
Lab tested by JanoshikIndependent third-party HPLC / mass-spec analysis for PT-141 10mg | 20-Vial Kit | Bremelanotide Kit. Each report carries a unique key you can verify directly with the lab.
Verify this report at janoshik.comPT-141 10mg | 20-Vial Kit | Bremelanotide Kit
PT-141 10mg | 20-Vial Kit — Bremelanotide MC3R/MC4R agonist — activates hypothalamic melanocortin receptors to drive central sexual arousal independently of…
10mg ·single research unit
Preorder
This size is not listed in the current warehouse stock sheet. Order now and dispatch origin will be confirmed before fulfilment.
Crypto checkout - discreet, tracked shipping
Research Use Only - not for human or veterinary consumption. Handling restricted to qualified researchers.
- Form
- Lyophilized powder
- Stock status
- Preorder
- Shipping
- Confirmed before fulfilment
- Payment
- USDC · USDT
Related compounds

KPV 30mg | 10-Vial Kit | Anti-Inflammatory Tripeptide
KPV 30mg | 10-Vial Kit | Anti-Inflammatory Tripeptide
QSC KPV (Alpha-MSH(11-13) C-terminal tripeptide) — ≥99% HPLC purity, MS confirmed, Janoshik COA.

TB-500 5mg | 10-Vial Kit | 50mg total | Thymosin Beta-4
TB-500 5mg | 10-Vial Kit | 50mg total | Thymosin Beta-4
TB-500 5mg | 10-Vial Kit — Thymosin beta-4 C-terminal fragment — sequesters G-actin to regulate cell migration and angiogenesis; studied for wound healing,…

ARA-290 10mg | 10-Vial Kit | 100mg total | Cibinetide
ARA-290 10mg | 10-Vial Kit | 100mg total | Cibinetide
QSC ARA-290 (Cibinetide) — innate repair receptor (IRR) agonist, EPO helix B peptide.

KPV 10mg | 10-Vial Kit | Anti-Inflammatory Tripeptide
KPV 10mg | 10-Vial Kit | Anti-Inflammatory Tripeptide
QSC KPV (Alpha-MSH(11-13) C-terminal tripeptide) — ≥99% HPLC purity, MS confirmed, Janoshik COA.
